Absorption, metabolism and excretion of 3H-semaglutide following a single, subcutaneous dose in healthy male subjects
#Pharma #Biotech #ObesityTreatment #ClinicalTrials To view or add a comment, sign in Pfizer breaks into obesity market in China with approval for Sciwind-partnered GLP-1 Less than two weeks after Pfizer struck a deal with Sciwind Biosciences to gain commercial rights to a GLP-1 drug, Chinas National Medical Products Administration (NMPA) has approved the treatment for patients with obesity
Drug Design, Development and Therapy, 14 , 951
To qualify for either medication, your BMI has to be over 30 (or above 27 with at least one weight-related condition like type 2 diabetes)
Moreover, Vitamin D helps reduce inflammation, leading to healthier, more radiant skin